Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome

Pediatric Nephrology

Volumn 29, Issue 7, 2014, Pages 1181-1187

  Kamei, Koichi ^a   Okada, Mari ^a   Sato, Mai ^a   Fujimaru, Takuya ^a   Ogura, Masao ^a   Nakayama, Makiko ^b   Kaito, Hiroshi ^c   Iijima, Kazumoto ^c   Ito, Shuichi ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

B cell; Immunosuppressive agents; Methylprednisolone pulse therapy; Rituximab; Steroid resistantnephrotic syndrome

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CHLORPHENIRAMINE MALEATE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PARACETAMOL; PODOCIN; PREDNISOLONE; RITUXIMAB; SERUM ALBUMIN; TACROLIMUS; WT1 PROTEIN; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADOLESCENT; AGRANULOCYTOSIS; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONGENITAL NEPHROTIC SYNDROME; COUGHING; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERTENSION; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H1N1); INFLUENZA VIRUS; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT SAFETY; PLASMAPHERESIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RASH; REMISSION; REPEATED DRUG DOSE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE DRUG DOSE; SORE THROAT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; WHEEZING; DRUG COMBINATION; DRUG RESISTANCE; NEPHROTIC SYNDROME; PROGNOSIS;

ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PROGNOSIS;

EID: 84901679630     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2765-z     Document Type: Article

References (23)

1. Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda M, Japanese Study Group of Renal Disease (2009) Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 24:2177-2185
2. Kidney Disease: Improving Global Outcomes (KDIGO) (2012) Steroid-resistant nephrotic syndrome in children. Kidney Int Suppl 2:172-176
3. Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269-1279
4. Kamei K, Ito S, Nozu K, Fujinaga S, NakayamaM, SakoM, SaitoM, Yoneko M, Iijima K (2009) Single dose of rituximab for refractory steroid-dependent nephritic syndrome in children. Pediatr Nephrol 24:1321-1328
5. Prytuła A, IijimaK,Kamei K, Geary D,Gottlich E,Majeed A, Taylor M,Marks SD, Tuchman S, Camilla R, Ognjanovic M, Filler G, Smith G, Tullus K (2010) Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 25:461-468
6. Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207-2212
7. Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K (2010) Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine. Pediatr Nephrol 25:539-544
8. Ito S, Kamei K, OguraM, SatoM, Fujimaru T, Ishikawa T, Udagawa T, Iijima K (2011)Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:1823-1828
9. Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood-follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083-1089
10. Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J (2012) Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 27:1910-1915
11. Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, SaitoM, Sako M, Iijima K (2013) Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediatr Nephrol 28:257-264
12. Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117-1124
13. Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751 - 2752
14. SuriM, TranK, Sharma AP, FillerG, Grimmer J (2008) Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol 40:807-810
15. Peters HP, van de Kar NC, Wetzels JF (2008) Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Neth J Med 66:408-415
16. Fernandez-Fresnedo G, Segarra A, González E, Alexandru S, Delgado R, Ramos N, Egido J, Praga M, for the Grupo de Trabajo de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) (2009) Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4:1317-1323
17. Chaumais MC, Garnier A, Chalard F, Peuchmaur M, Dauger S, Jacqz-Agrain E, Deschênes G (2009) Fatal pulmonary fibrosis after rituximab administration. Pediatr Nephrol 24:1753-1755
18. Kari JA, El-Morshedy SM, El-Desoky S, Alshaya HO, Rahim KA, Edrees BM (2011) Rituximab for refractory cases of childhood nephrotic syndrome. Pediatr Nephrol 26:733-737
19. Hirano D, Fujinaga S, Nishizaki N (2012) The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome. Clin Nephrol 77:510-512
20. Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 23:481-485
21. Kaito H, Kamei K, Kikuchi E, Ogura M, Matsuoka K, Nagata M, Iijima K, Ito S (2010) Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatr Nephrol 25:957-959
22. Nagai T, Uemura O, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, HondaM(2013) Creatinine-based equations to estimate glomerular filtration rate in Japanese children aged between 2 and 11 years old with chronic kidney disease. Clin Exp Nephrol 17:877-881
23. Fornoni A, Sageshima J,Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85-95